title: The link between lipids, statins and cancer: is there a role for cardio-oncology?
authors.affiliation: John Ochsner Heart & Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, 1514 Jefferson Highway, New Orleans, LA 70121, USA.
authors.forename: Eiman
authors.initials: E
authors.lastname: Jahangir
authors.affiliation: John Ochsner Heart & Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, 1514 Jefferson Highway, New Orleans, LA 70121, USA.
authors.forename: Nichole M
authors.initials: NM
authors.lastname: Polin
authors.affiliation: John Ochsner Heart & Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, 1514 Jefferson Highway, New Orleans, LA 70121, USA.
authors.forename: Carl J
authors.initials: CJ
authors.lastname: Lavie
authors.affiliation: Center for Preventive Cardiology, Oregon Health & Science University; 3181 Sam Jackson Park Road, Portland, OR 97239, USA.
authors.forename: Sergio
authors.initials: S
authors.lastname: Fazio
mesh_terms: D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000150:complications* / Q000188:drug therapy; D009369:Neoplasms / Q000453:epidemiology*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: HMG-CoA reductase inhibitors; cancer; cardio-oncology; cholesterol; lipids; statins